Osteoarthritis affects around 600 million people globally. It causes pain, stiffness, and reduced joint function—most commonly in the knees, hands, and hips.

While these side effects can often improve over time, users have been hit with nausea, vomiting, diarrhoea, abdominal pain, and constipation, which commonly occur as they increase their dosage.

A twice-yearly injection may soon change how high blood pressure is treated. In a global trial, patients receiving the experimental drug zilebesiran alongside standard therapy saw greater blood ...

A recent FDA approval means consumers now have to GLP-1 weight loss pills to choose from as an alternative to the traditional ...

A joystick-like robot lets Emory doctors guide a tiny wire to blocked blood vessels, offering precise, minimally invasive ...

Using an LPS-induced ALI mouse model and LPS-stimulated alveolar macrophages, they found XBJ reduced inflammatory cytokine ...

Health and wellness influencers are hawking unapproved treatments on the gray market. The future of the F.D.A.—and the health ...

A phase 1/2 trial of a novel viral vector gene therapy in adults with type 1 diabetes is scheduled to begin this year.

Tirzepatide (Zepbound, Mounjaro) is a dual-agonist GLP-1 medication. It works like a GLP-1 agonist, but also targets a hormone called glucose-dependent insulinotropic polypeptide (GIP) to “help break ...

Injectable peptides are licensed ‘for research use only’, but that doesn’t deter biohackers from selling them or gym goers from conducting their own experiments with unregulated vials ordered from the ...

High blood pressure is one of the most common health problems in the world. Millions of people live with it, and many may not even realize they have it because it often causes no clear symptoms.